Quest Diagnostics Inc - Company Profile
Powered by 
All the sales intelligence you need on Quest Diagnostics Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Quest Diagnostics Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Quest Diagnostics Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Quest Diagnostics Inc (Quest Diagnostics) is a healthcare company engaged in providing diagnostic information services to patients and physicians through a network of laboratories and company-owned patient service centers. It offers an array of services, including clinical testing with gene-based and other esoteric tests, anatomic pathology services, clinical trial testing, life insurer services, and various healthcare information technology and diagnostic products. The company's products and services are utilized by physicians, hospitals, patients, health plans, and government agencies across various healthcare sectors. Quest Diagnostics operates through a network of laboratories and patient service centers. The company has operations in North America, Asia Pacific, South America, and Europe. Quest Diagnostics is headquartered in Secaucus, New Jersey, the US.
Headquarters
United States of America
Address
500 Plaza Drive, Secaucus, New Jersey, 07094
Website
www.questdiagnostics.com
Telephone
1 973 5202700
No of Employees
46,000
Industry
Medical Equipment
Ticker Symbol & Exchange
DGX (NYSE)
Revenue (2024)
$11.0B
6.7%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
2%
(2024 vs 2023)
Market Cap*
$25.2B
Net Profit Margin (2023)
XYZ
-4.4%
(2024 vs 2023)
* As of and is in US$
Quest Diagnostics Inc premium industry data and analytics
Products and Services
| Services | Brands |
|---|---|
| Diagnostic Testing Services | AmeriPath |
| Clinical Trials | Athena |
| Anatomic Pathology Services | AccuType |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | Others | In July, the company integrated its Haystack MRD and genomic profiling tests into Flatiron's OncoEMR. |
| 2026 | Contracts/Agreements | In January, the company and Corewell Health formed a joint venture to enhance access to innovative and affordable lab services in Michigan, the US. |
| 2026 | Contracts/Agreements | In January, the company and Labcorp partnered with Visby Medical to expand national access to the Visby Women's Sexual Health Test. |
Competitor Comparison
| Key Parameters | Quest Diagnostics Inc | Thermo Fisher Scientific Inc | Labcorp Holdings Inc | Novant Health Inc | Bio-Rad Laboratories Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | Secaucus | Waltham | Burlington | Charlotte | Hercules |
| State/Province | New Jersey | Massachusetts | North Carolina | North Carolina | California |
| No. of Employees | 46,000 | 125,000 | 71,000 | - | 7,450 |
| Entity Type | Public | Public | Public | Private | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| James E. Davis | Chairman; Chief Executive Officer; President | Executive Board | 2023 | 63 |
| Sam A. Samad | Chief Financial Officer; Executive Vice President | Senior Management | 2022 | 56 |
| Benjamin Beauvalot | Senior Vice President; Chief Strategy Officer; Chief M&A Officer | Senior Management | 2025 | - |
| Kristin Wallace | Senior Vice President; Chief Compliance Officer | Senior Management | 2022 | - |
| Yuri A. Fesko, MD | Senior Vice President; Chief Medical Officer | Senior Management | 2023 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer